Engagements are led by a team of skilled vigilance experts who understand the requirements of regulators, client challenges, and the evolving landscape.
Tailored services to meet clients’ changing needs including flexibility to respond rapidly to project demands and deviations and achieve long-term client loyalty.
Robust infrastructure with standardized processes supported by tools to monitor workflows, to deliver class-leading efficiency for clients.
Intake, processing, review, follow-up and reporting of adverse device effect (ADE) and medical device incident (MDI) in clinical and post-marketing settings
AI-enabled literature screening to reduce the need for in-depth review of literature citations and abstracts by up to 50%, leveraging machine-assisted learning for enhanced precision and compliance.
Strategic advisory services to support post-market surveillance services including post-market surveillance plans (PMSP) and post-market clinical follow-up plans (PMCFP).
Generation of high quality global safety reports including periodic safety update reports (PSURs), post-market surveillance (PMS) reports, and risk management plans (RMPs) along with signal detection and management reports.
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274